Mengna Kang (盟纳康)盟纳康
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京智飞绿竹生物制药有限公司Chinese legal name: 北京智飞绿竹生物制药有限公司
主要成分Active Ingredients
- 经提取获得的荚膜多糖抗原Jingti Quhuo Dede Jiamo Duotang Kangyuan
药物知识说明
经提取获得的荚膜多糖抗原是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：经提取获得的荚膜多糖抗原Jingti Quhuo Dede Jiamo Duotang Kangyuan。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：经提取获得的荚膜多糖抗原-a4118ab5成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盟纳康) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 经提取获得的荚膜多糖抗原Jingti Quhuo Dede Jiamo Duotang Kangyuan.
Explore other medicines containing the same ingredient: 经提取获得的荚膜多糖抗原 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盟纳康Recorded Chinese name: 盟纳康
- 规格Specification: 每瓶0.5ml,每1次人用剂量0.5ml,含与破伤风类毒素结合的A群、C群脑膜炎球菌多糖各10μg。Recorded Chinese description: 每瓶0.5ml,每1次人用剂量0.5ml,含与破伤风类毒素结合的A群、C群脑膜炎球菌多糖各10μg。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京智飞绿竹生物制药有限公司Chinese legal name: 北京智飞绿竹生物制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字S20070018
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字S20070018
Manufacturer
Chinese legal name: 北京智飞绿竹生物制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字S20070018
生产企业
北京智飞绿竹生物制药有限公司(国产)
适应症
1.接种本疫苗后，可使机体产生体液免疫应答，用于预防A、C群脑膜炎球菌引起的感染性疾病，如脑脊髓膜炎、肺炎等。|2.此疫苗不能预防其他病菌引起的感染，亦不能预防其他原因引起的脑膜炎、肺炎等疾病。
用法用量
1.用前充分摇匀。|2.上臂外侧三角肌附着处肌肉内注射0.5ml。|3.根据目前临床研究结果,推荐以下免疫程序：|(1)3-12月龄儿童：基础免疫3次，间隔1个月注射一次。|(2)1-2岁儿童基础免疫注射2次，间隔1个月注射一次。|(3)3岁以上儿童或成人基础免疫注射1次。
不良反应
1.本疫苗偶有短暂的发热、皮疹等不良反应。|2.注射局部有可能出现疼痛、红肿或硬结，可自行缓解。|3.极少数的儿童还可能出现嗜睡或烦躁。
禁忌
1.对疫苗的成分,尤其是对破伤风类毒素过敏者禁用。|2.癫痫、抽风、脑部疾患者禁用。|3.肾脏病、心脏病、活动性结核患者及HIV感染者禁用。|4.患急性传染病及发热者禁用。
注意事项
1.本疫苗溶液为白色悬浊液，可因长时间放置而分层，用前必须摇匀。|2.使用前应仔细检查，如瓶塞有松动或瓶内有摇不散的佐剂团块，不得使用。|3.注射器针头不可刺破血管，严禁静脉或动脉内注射。|4.与其他疫苗一样，在发热或急性感染期尽量避免接种。|5.本品未进行与其它疫苗同时接种的临床研究，与其它疫苗之间是否存在相互干扰未知，应尽量避免同时接种，以免影响疫苗的效果。|6.在瓶签标明的有效期内使用。
贮藏
密闭
规格
每瓶0.5ml,每1次人用剂量0.5ml,含与破伤风类毒素结合的A群、C群脑膜炎球菌多糖各10μg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.